Results of the first external quality assessment scheme (EQA) for isolation and analysis of circulating tumour DNA (ctDNA)
暂无分享,去创建一个
S. Patton | V. Haselmann | P. Ahmad-Nejad | W. Geilenkeuser | Angelika Duda | Merle Gabor | Romy Eichner | M. Neumaier
[1] H A Erlich,et al. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. , 1986, Nature.
[2] Henry A. Erlich,et al. Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes , 1986, Nature.
[3] H A Erlich,et al. Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[4] S. Spitzer,et al. Single nucleotide primer extension to detect genetic diseases: experimental application to hemophilia B (factor IX) and cystic fibrosis genes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[5] S H Neoh,et al. Quantitation of targets for PCR by use of limiting dilution. , 1992, BioTechniques.
[6] P. Vos,et al. AFLP: a new technique for DNA fingerprinting. , 1995, Nucleic acids research.
[7] M. Neumaier,et al. Experiences with External Quality Assessment (EQA) in Molecular Diagnostics in Clinical Laboratories in Germany , 2000, Clinical chemistry and laboratory medicine.
[8] F. O. Fackelmayer,et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. , 2001, Cancer research.
[9] W. Grody,et al. Quality control in molecular genetic testing , 2001, Nature Reviews Genetics.
[10] S. Little,et al. Amplification‐Refractory Mutation System (ARMS) Analysis of Point Mutations , 1995, Current protocols in human genetics.
[11] Frank Diehl,et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[12] Frank Diehl,et al. BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions , 2006, Nature Methods.
[13] M. Fleischhacker,et al. Circulating nucleic acids (CNAs) and cancer--a survey. , 2007, Biochimica et biophysica acta.
[14] K. Kinzler,et al. Serial assessment of human tumor burdens in mice by the analysis of circulating DNA. , 2007, Cancer research.
[15] P. Pernet,et al. Specific real-time PCR vs. fluorescent dyes for serum free DNA quantification , 2007, Clinical chemistry and laboratory medicine.
[16] G. Makrigiorgos,et al. COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing. , 2009, Biochemical Society transactions.
[17] V. Sintchenko,et al. Multiplex PCR and Reverse Line Blot Hybridization Assay (mPCR/RLB) , 2011, Journal of visualized experiments : JoVE.
[18] Cas Weykamp,et al. Proficiency testing/external quality assessment: current challenges and future directions. , 2011, Clinical chemistry.
[19] Klaus Pantel,et al. Cell-free nucleic acids as biomarkers in cancer patients , 2011, Nature Reviews Cancer.
[20] Kikuya Kato,et al. Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas , 2011, Clinical Cancer Research.
[21] Sarah Berwouts,et al. Quality assurance practices in Europe: a survey of molecular genetic testing laboratories , 2012, European Journal of Human Genetics.
[22] Johannes G. Reiter,et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers , 2012, Nature.
[23] Jorge S. Reis-Filho,et al. Going with the Flow: From Circulating Tumor Cells to DNA , 2013, Science Translational Medicine.
[24] M. Zavoral,et al. Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients. , 2013, Analytical biochemistry.
[25] Daniel F. Hayes,et al. Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer , 2013 .
[26] S. Gelmini,et al. SPIDIA-DNA: an External Quality Assessment for the pre-analytical phase of blood samples used for DNA-based analyses. , 2013, Clinica chimica acta; international journal of clinical chemistry.
[27] R. Murthy,et al. Use of research biopsies in clinical trials: are risks and benefits adequately discussed? , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] F. Mouliere,et al. Circulating cell free DNA: Preanalytical considerations. , 2013, Clinica chimica acta; international journal of clinical chemistry.
[29] Alison S. Devonshire,et al. Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification , 2014, Analytical and Bioanalytical Chemistry.
[30] L. Diaz,et al. Liquid biopsies: genotyping circulating tumor DNA. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] J. Utikal,et al. Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial , 2015, The Lancet.
[32] フランク ディール,et al. Circulating mutant dna to assess tumor dynamics , 2015 .
[33] Matthew Wongchenko,et al. Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial. , 2016, The Lancet. Oncology.
[34] W. Tam,et al. Novel therapeutic targets on the horizon for lung cancer. , 2016, The Lancet. Oncology.
[35] Matthew W. Snyder,et al. Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin , 2016, Cell.
[36] H. Dosaka-akita,et al. Role of targeted therapy in metastatic colorectal cancer , 2016, World journal of gastrointestinal oncology.
[37] V. Haselmann,et al. Thirteen Years of an International External Quality Assessment Scheme for Genotyping: Results and Recommendations. , 2016, Clinical chemistry.
[38] N. Dhomen,et al. Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma. , 2016, Cancer discovery.
[39] A. Torkamani,et al. Liquid Biopsies for Cancer: Coming to a Patient near You , 2017, Journal of clinical medicine.